期刊文献+

多塞平对骨癌疼痛模型大鼠的镇痛作用研究 被引量:1

Analgesic Effect of Doxepin on Bone Cancer Pain Model Rats
原文传递
导出
摘要 目的:研究多塞平对骨癌疼痛模型大鼠的镇痛作用。方法:取大鼠90只,其中10只为正常组,另80只胫骨注射含人乳腺癌Walker256细胞株的大鼠细胞液建立骨癌疼痛模型,待模型成功稳定后分为模型组、吗啡组(1000μg·kg-1)、多塞平(3、10、30、100、300、1000μg·kg-1)组,鞘内给予相应药物,考察给药后0.5、1、2、4h时各组大鼠的双侧脚痛阈值,并计算多塞平的最大镇痛效应。结果:多塞平与吗啡在给药后0.5h即产生镇痛作用,给药后1h镇痛作用达到高峰;多塞平各剂量组大鼠造模对侧脚痛阈值无明显变化,造模同侧脚痛阈值升高与剂量呈正相关;多塞平1000μg·kg-1的最大镇痛效应为67.7%,半数有效量为46.6μg·kg-1,与吗啡1000μg·kg-1的镇痛效应比较无明显差异。结论:多塞平对骨癌疼痛模型大鼠具有镇痛作用。 OBJECTIVE: To study the analgesia effect of doxepin on the bone cancer pain rats. METHODS: Of total 90 rats, 10 rats were included in normal group and other 80 rats were injected with Walker256 cell to build the bone cancer pain model. Then those model rats were divided into model group, morphine group (1 000 μg·kg-1) and doxepin groups (3, 10, 30, 100, 300, 1 000 μg·kg-1). Those groups were given relevant medicine intrathecally. The pain thresholds of bilateral foot of rats were detected at 0.5, 1, 2, 4 h after medication, and maximum analgesia effect of doxepin was calculated. RESULTS: Doxepin and morphine exerted analgesia effect at 0.5 h, and reached the top at 1 h. Contralateral paw pain thresholds in doxepin groups had no significant change, and the increase of ipsilateral paw pain thresholds was positively related with dose; maximum analgesic efficacy of doxepin (1 000 μg·kg-1) was 67.7%, and median effective dose was 46.6 μg·kg-1. There was no significant difference in the analgesic effect between doxepin 1 000 μg·kg-1 group and morphine 1 000 μg·kg-1 group. CONCLUSION: Doxepin has beneficial effect of analgesia for bone cancer pain rats
出处 《中国药房》 CAS CSCD 2012年第1期31-33,共3页 China Pharmacy
关键词 多塞平 骨癌疼痛 大鼠 鞘内注射 镇痛 Doxepin Bone cancer pain Rats Intrathecal injection Analgesic effect
  • 相关文献

参考文献10

  • 1Luger NM, Mach DB, Sevcik MA, et al. Bone cancer pain: from model to mechanism to therapy[J]. J Pain Symptom Manage, 2005,29 (5 Suppl) : S32.
  • 2Garcia X, del Valle J, Escribano E, et al. Analgesic and antiallodynic effects of antidepressants after infiltration into the rat[J]. Pharmacology,2010, 86(4) :216.
  • 3Gemer P, Srinivasa V, Zizza AM, et al. Doxepin by topical application and intrathecal route in rats[J]. Anesth Analg,2006, 102(1) :283.
  • 4Epstein JB, Epstein JD, Epstein MS, et al.Oral doxepin rinse: the analgesic effect and duration of pain reduction in patients with oral mucositis due to cancer therapy[J]. Anesth Analg, 2006, 103 (2) : 465.
  • 5Wordliczek J, Banach M, Labuz D, et al. Intrathecal administration of doxepin attenuated development of formalin-induced pain in rats[J]. J Neural Transm, 2005, 112 (10):1 321.
  • 6Gong N, Gao ZY, Wang YC, et al. A series of D-amino acid oxidase inhibitors specifically prevents and reverses formalin-induced tonic pain in rats[J]. J Pharmacol Exp Ther,2011, 336(1) :282.
  • 7Mao-Ying QL, Zhao J, Dong ZQ, et al. A rat model of bone cancer pain induced by intra-tibia inoculation of Walker 256 mammary gland carcinoma cells[J]. Biochem Biophys Res Commun, 2006, 345(4) : 1 292.
  • 8Nieder C, Haul(land E, Pawinski A, et al. Pathologic fracture and metastatic spinal cord compression in patients with prostate cancer and bone metastases[J]. BMC Urol, 2010, 10:23.
  • 9李晓青,孙玉明,黄章翔,王妙苗,吴镜湘,缪雪蓉,徐爱民,朱忠正,赵志奇,俞卫锋.Walker256乳腺癌细胞构建大鼠胫骨骨癌痛模型[J].中国肿瘤生物治疗杂志,2008,15(1):41-45. 被引量:28
  • 10Cheng BC, Chan BR, Chert YW, et al. Doxepin has a potent and long-acting spinal anesthetic effect in rats[J]. Kaohsiung J Med Sci , 2006,22 (2) : 68.

二级参考文献20

  • 1Cleeland CS. The measurement of pain from metastatic bone disease: capturing the patient's experience [ J]. Clin Cancer Res, 2006, 12(20 Pt 2) : s 6236- s 6242.
  • 2Kasai Y, Uehida A. Quality of life in patients with metastatic spinal tumors[J]. Clin Calcium, 2006,16(4) : 598-603.
  • 3Thtirlimann B, de Stoutz ND. Causes and treatment of bone pain of malignant origin[ J]. Drugs, 1996, 51 (3) : 383-398.
  • 4Mercadante S, Arcuri E. Breakthrough pain in cancer patients: pathophysiology and treatment [ J ]. Cancer Treat Rev, 1998, 24 (6) : 425-432.
  • 5Mantyh PW, Clohisy DR, Koltzenburg M, et al. Molecular mecha-nisms of cancer pain[J]. Nat Rev Cancer, 2002, 2(3) : 201-209.
  • 6Saad F, Perrotte P, Benard F, et al. Bone health in men with prostate cancer: diagnostic and therapeutic considerations [ J ]. Can J Urol, 2005,12(Suppl 2) : 9-15.
  • 7Ahn H, Mousavi P, Roth S,et al. Stability of the metastatic spine pre and post vertebroplasty[J]. J Spinal Disord Tech,2006, 19 (3) :178-182.
  • 8Simpkins H, Lehman JM, Mazurkiewicz JE, et al. A morphological and phenotypic analysis of Walker 256 cells[ J ]. Cancer Res, 1991,51 (4) :1334-1338.
  • 9Honore P, Rogers SD, Schwei M J, et al. Murine models of infla mmatory, neuropathie and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons[J].Neuroscienee, 2000, 98(3) :585-598.
  • 10McBride WH. Phenotype and functions of intratumoral macrophages [ J]. Biochim Biophys Acta, 1986, 865( 1 ) : 27-41.

共引文献27

同被引文献27

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部